The High Cost of Death After Acute Myocardial Infarctions: Results from a National US Hospital Database.

IF 2.1 Q3 HEALTH CARE SCIENCES & SERVICES

ClinicoEconomics and Outcomes Research Pub Date : 2023-01-01 DOI:10.2147/CEOR.S397220

Peter J Mallow, Frederick Browne, Kamal Shemisa

{"title":"The High Cost of Death After Acute Myocardial Infarctions: Results from a National US Hospital Database.","authors":"Peter J Mallow, Frederick Browne, Kamal Shemisa","doi":"10.2147/CEOR.S397220","DOIUrl":null,"url":null,"abstract":"Introduction: This study described the differences in costs and length of stay (LOS) among patients with AMI who died versus survived using a large, nationally representative cohort of AMI patients.Methods: The 2019 HCUP NIS was used to analyze costs, and LOS among all patients with a principal diagnosis of AMI. A propensity-score matched analysis and multivariable regression were used to adjust for patient and hospital characteristics.Results: There were 4559 visits in each of the cohorts (total 9118). The adjusted mean hospital cost was $18,970 (95% CI $16,453 - $21,871) for those that survived and $23,173 (95% CI $20,167 - $26,626; p <0.001) for those that died. The LOS was 3.95 (95% CI 3.41-4.57) in survivors and 4.24 (95% CI 3.67-4.89; p <0.001) in those who died.Conclusion: Survivors of AMI incurred lower costs and length of stay than those who died. Higher costs were attributed to greater LOS and higher-level care. The results suggest that economic evaluations of cardiovascular interventions that do not include the cost of dying may underestimate the benefits of the intervention.","PeriodicalId":47313,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/02/ceor-15-63.PMC9899015.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ClinicoEconomics and Outcomes Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/CEOR.S397220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 1

Abstract

Introduction: This study described the differences in costs and length of stay (LOS) among patients with AMI who died versus survived using a large, nationally representative cohort of AMI patients.

Methods: The 2019 HCUP NIS was used to analyze costs, and LOS among all patients with a principal diagnosis of AMI. A propensity-score matched analysis and multivariable regression were used to adjust for patient and hospital characteristics.

Results: There were 4559 visits in each of the cohorts (total 9118). The adjusted mean hospital cost was $18,970 (95% CI $16,453 - $21,871) for those that survived and $23,173 (95% CI $20,167 - $26,626; p <0.001) for those that died. The LOS was 3.95 (95% CI 3.41-4.57) in survivors and 4.24 (95% CI 3.67-4.89; p <0.001) in those who died.

Conclusion: Survivors of AMI incurred lower costs and length of stay than those who died. Higher costs were attributed to greater LOS and higher-level care. The results suggest that economic evaluations of cardiovascular interventions that do not include the cost of dying may underestimate the benefits of the intervention.

查看原文本刊更多论文

急性心肌梗死后死亡的高成本:来自美国国家医院数据库的结果

本研究描述了AMI患者死亡与存活的成本和住院时间(LOS)的差异，使用了一个大型的、具有全国代表性的AMI患者队列。方法:使用2019年HCUP NIS分析所有主要诊断为AMI的患者的成本和LOS。使用倾向评分匹配分析和多变量回归来调整患者和医院的特征。结果:每个队列共就诊4559人次(共9118人次)。幸存者调整后的平均住院费用为18,970美元(95% CI为16,453 - 21,871美元)，23,173美元(95% CI为20,167 - 26,626美元;结论:急性心肌梗死幸存者的费用和住院时间低于死亡患者。更高的费用归因于更高的LOS和更高水平的护理。结果表明，不包括死亡成本的心血管干预的经济评估可能低估了干预的好处。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊